Camptothecin-resistant Mutants of Chinese Hamster Ovary Cells Containing a Resistant Form of Topoisomerase I

Cancer Research

Volumn 48, Issue 22, 1988, Pages 6404-6410

  Gupta, Radhey S ^a   Gupta, Rajni ^a   Eng, Barry ^a   Lock, Richard ^b   Ross, Warren ^b   Hertzberg, Robert P ^c   Caranfa, Mary Jo ^c   Johnson, Randall K ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF FLORIDA   (United States)

^c Smith Kline and Beecham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; CAMPTOTHECIN; COLCHICINE; DNA TOPOISOMERASE; DOXORUBICIN; ELLIPTICINE; ETOPOSIDE; MITOXANTRONE; PUROMYCIN; TAXOL; TENIPOSIDE; VINBLASTINE;

ANIMAL CELL; CELL CULTURE; CELL MUTANT; CHO CELL; DRUG RESISTANCE; HAMSTER; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; CAMPTOTHECIN; CRICETULUS; DNA DAMAGE; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE; HAMSTERS; HYBRID CELLS; MUTATION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023739308     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Wang, J. S. DNA topoisomerases. Annu. Rev. Biochem., 54: 665-697. 1985.
2. Zwelling, L. A., Michaels, S., Erickson, L. C., Ungerleider, R. S., Nichols, M., and Kohn, K.W. Protein-associated DNA strand breaks in LI210 cells treated with the DNA intercalating agents 4'-(9-acridinylamino)-methanesulfon-m-anisidide and Adriamycin. Biochemistry, 20: 6553-6563, 1981.
3. Wozniak, A. J., and Ross, W. E. DNA damage as a basis for 4'-demethylepipodophyllotoxin-9-(4, 6-O-ethylidene-β-D-glucopyranoside) (etoposide) cytotoxicity. Cancer Res., 43: 120-124, 1983.
4. Nelson, E. M., Tewey, K. M., and Liu, L. F. Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide. Proc. Natl. Acad. Sci, USA, 81: 1361-1365, 1984.
5. Tewey, K. M., Chen, G. L., Nelson, E. M., and Liu, L. F. Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J. Biol. Chem., 259: 9182-9187, 1984.
6. Chen, G. L., Yang, L., Rowe, T. C., Halligan, B. D., Tewey, K. M., and Liu, L. F. Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J. Biol. Chem., 259: 13560-13566, 1984.
7. Ross, W., Rowe, T., Glisson, B., Yalowich, J., and Liu, J. Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. Cancer Res., 44: 5857-5860. 1984.
8. Minocha. A., and Long. B. H. Inhibition of the DNA catenation activity of type II topoisomerase by VP16-213 and VM26. Biochem. Biophys. Res. Commun., 122: 165-170, 1984.
9. Ross. W. E. DNA topoisomerases as targets for cancer therapy. Biochem. Pharmacol., 34: 4191-4195, 1985.
10. Salles, B., Chariosset, J. Y., and Jacquelin-Sablon, A. Isolation and properties of Chinese hamster lung cells resistant to ellipticine derivatives. Cancer Treat. Rep., 66: 327-338, 1982.
11. Gupta, R. Genetic, biochemical and cross-resistance studies with mutants of Chinese hamster ovary cells resistant to the anticancer drugs, VM-26 and VP16-213. Cancer Res., 43: 1568-1574, 1983.
12. Lee, T., and Roberts, D. Selection and characterization of L1210 sublines resistant to teniposide (VM-26). Cancer Res., 44: 2981-2985, 1984.
13. Glisson, B., Gupta, R., Hodges. P., and Ross, W. Cross-resistance to intercalating agents in an epipodophyllotoxin-resistant Chinese hamster ovary cell line: evidence for a common intracellular target. Cancer Res., 46: 1939-1942, 1986.
14. Glisson, B., Gupta. R., Smallwood-Kentro. S., and Ross, W. Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug-stimulated DNA cleavage activity. Cancer Res., 46: 1934-1938, 1986.
15. Pommier. Y., Kerrigan, D., Schwartz, R. E., Swack, J. A., and McCurdy, A. Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors. Cancer Res., 46: 3075-3081. 1986.
16. Pommier, Y., Schwartz, R. E., Zwelling, L. A., Kerrigan. D., Mattern, M. R., Chariosset, J. Y., Jacquelin-Sablon, A., and Kohn, K. W. Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors. Cancer Res., 46: 611-616, 1986.
17. Per, S. R., Mattern, M. R., Mirabelli, C. K., Drake, F. H., Johnson, R. K., and Crooke, S. T. Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function. Mol. Pharmacol., 32: 17-25, 1987.
18. Danks, M. K., Yalowich, J. C., and Beck, W. T. Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide. Cancer Res., 47: 1297-1301. 1987.
19. Gupta, R. S., and Ross, W. E. Resistance to etoposide (VP 16) and teniposide (VM26) in mammalian cells (in press). In: R. S. Gupta (ed.), Drug Resistance in Mammalian Cells (in press). Boca Raton, FL: CRC Press, 1989.
20. Gupta, R. S., Chenchaiah, P. C., and Gupta, R. Synthesis and structureactivity relationship among glycosidic derivatives of 4'-demethylepipodophyllotoxin and epipodophyllotoxin, showing VM26- and VP16-213-like activity. Anti-Cancer Drug Design, 2: 1-12, 1987.
21. Wall, M. E., Wani, M C., and Cook, C. E. Plant antitumor agents. 1. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptolheca acuminata. J. Am. Chem. Soc., 83: 3888-3890, 1966.
22. Gallo, R. C., Whang-Peng, J., and Adamson, R. H. Studies on the antitumor activity, mechanism of action and the cell cycle effects of camptothecin. J. Natl. Cancer Inst., 46: 789-795, 1971.
23. Horowitz, S. B. Camptothecin. In: J. W. Corcoran and F. E. Hahn (eds.), Antibiotics. Vol. 3, pp. 48-57. Berlin: Springer-Verlag, 1975.
24. Kessel, D., Bosmann, H. B., and Lohr, K. Camptothecin effects on DNA synthesis in murine leukemia cells. Biochim. Biophys. Acta, 269: 210-216, 1972.
25. Hsiang, Y. H., Hertzberg, R., Hecht, S., and Liu, L. F. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem., 260: 14873-14878. 1985.
26. Maltern, M. R., Mong, S. M., Bartus, H. F., Mirabelli, C. K., Crooke, S. T., and Johnson. R. K. Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells. Cancer Res., 47: 1793-1798. 1987.
27. Gupta, R. S. Resistance to the microtubule inhibitor podophyllotoxin: selection and partial characterization of mutants in CHO cells. Somat. Cell Genet., 7: 59-71, 1981.
28. Gupta, R. S., Chan, D. H. Y., and Siminovitch, L. Evidence obtained by segregation analysis for functional hemizygosity at the emf locus in CHO cells. Cell, 14: 1007-1013, 1978.
29. Norwood, T. H., Zeigler, C. J., and Martin, G. M. Dimethyl sulfoxide enhances polyethylene glycol-mediated somatic cell fusion. Somat. Cell Genet., 2: 263-270, 1976.
30. Gupta. R. S. Podophyllotoxin resistant mutants of Chinese hamster ovary cells: cross-resistance studies with various microtubule inhibitors and podophyllotoxin analogs. Cancer Res., 43: 505-512, 1983.
31. Kohn, K. W., Ewig, R. A. G., Erickson, L. C., and Zwelling, L. A. Measurements of strand breaks and cross-links by alkaline elution. In: E. C. Friedberg and P. C. Hanawalt (eds.), DNA Repair: A laboratory Manual of Research Techniques, pp. 379-401. New York, Marcel Dekker, 1981.
32. Halligan, B. D., Davis, J. L., Edwards, K. A., and Liu, L. F. Intra- and intermolecular strand transfer by HeLa DNA topoisomerase I. J. Biol. Chem., 257: 3995-4000, 1982.
33. Taylor, D. P., and Cohen, S. N. Structural and functional analysis of cloned DNA segments containing the replication and incompatibility regions of a multiple plasmid derived from a copy number mutant of NRI. J. Bacteriol., 757: 92-104, 1979.
34. Englund, P. T. The replication of kinetoplast DNA networks in Crithidia fasciculata. Cell, 14: 157-168, 1978.
35. Liu, L. F., and Miller, K. G. Eukaryotic DNA topoisomerase: two forms of type I DNA topoisomerases from hela cell nuclei. Proc. Natl. Acad. Sci. USA, 78: 3487-3491, 1981.
36. Gupta, R. S. Cross resistance of vinblastine- and taxol-resistant mutants of Chinese hamster ovary cells to other anticancer drugs. Cancer Treat. Rep., 69: 515-521, 1985.
37. Biedler, J. L., Chang, T., Meyers, M. B., Peterson, R. H. F., and Spengler, B. A. Drug resistance in Chinese hamster lung and mouse tumor cells. Cancer Treat. Rep., 67: 859-867, 1983.
38. Beck, W. T. Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblasts. Cancer Treat. Rep., 67: 875-882, 1983.
39. Riordan, J. R., and Ling, V. Genetic and biochemical characterization of multidrug resistance. Pharmacol. Ther., 28: 51-75, 1985.
40. Szybalski, W., and Szybalska, E. H. Drug sensitivity as a marker for human cell lines. Univ. Mich. Med. Bull., 28: 277-293, 1962.
41. Andoh, T., Ishii, K., Suzuki, Y., Ikegami, Y., Kusunoki, Y., Takemoto, U., and Okada, K. Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I. Proc. Natl. Acad. Sci. USA, 84: 5565-5569, 1987.
42. Kjeldsen, E., Borven, B. J., Andoh, T., Ishii, K., Okada, K., Bolund, L., and Westergaard, O. Characterization of a camptothecin-resistant human DNA topoisomerase I. J. Biol. Chem., 263: 3912-3916, 1988.
43. Uemura, T., and Yanagida, M. Isolation of type I and type II DNA topoisomerase mutants from fission yeast. Single and double mutants show different phenotypes in cell growth and chromatin organization. EMBO J., 5: 1737-1744, 1984.
44. Marsh, C., Vollkel, K. A., DiNardo, S., and Sternglanz, R. Identification of Saccharomyces cereviseae mutants defective in DNA topoisomerase I activity. J. Biol. Chem., 259: 1375-1377, 1984.
45. Zeng, G.-C., Hadjopoulos, M. Z., Ozer, H. L., and Hand, R. Defective DNA topoisomerase I activity in a DNA mutant of Balb/3T3 cells. Somat. Cell Mol. Genet., 11: 557-569, 1985.
46. Sullivan, D. M., Glisson, B. S., Hodges, P. K., Smallwood-Kentro, S., and Ross, W. E. Proliferation dependence of topoisomerase II mediated drug action. Biochemistry, 25: 2248-2286, 1986.
47. Campbell, C. E., and Worton, R. G. Evidence obtained by induced mutation frequency analysis for functional hemizygosity at the emt locus in CHO cells. Somat. Cell Genet., 5: 51-65, 1979.
48. Gupta, R. S., Chan, D. H. Y., and Siminovitch, L. Evidence for variation in the number of functional gene copies at the amar locus in Chinese hamster cells. J. Cell. Physiol., 97: 461-467, 1978.
49. Simon, A. E., and Taylor, M. W. High-frequency mutation at the adenine phosphoribosyl transferase locus in Chinese hamster ovary cells due to deletion of the gene. Proc. Natl. Acad. Sci. USA, 80: 810-814, 1983.
50. Simon, A. E., Taylor, M. W., Bradley, W. E. C., and Thompson, L. H. Model involving gene inactivation in the generation of autosomal recessive mutants in mammalian cells in culture. Mol. Cell. Biol., 2: 1126-1133, 1982.
51. Adair, G. M., Stallings, R. L., Nairn, R. S., and Siciliano, M. J. Highfrequency structural gene deletion as the basis for functional hemizygosity of the adenine phosphoribosyl-transferase locus in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA, 80: 5961-5964, 1983.
52. Eves, E. M., and Farber, R. A. Chromosome segregation is frequently associated with the expression of recessive mutations in mouse cells. Proc. Natl. Acad. Sci. USA, 78: 1768-1772, 1981.